Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and epidemiological characteristics of mpox: A descriptive cases series in Colombia.
Álvarez-Moreno CA, Alzate-Ángel JC, De La Hoz-Siegler IH, Bareño A, Mantilla M, Sussman O, Valderrama-Beltrán S, Rodriguez JY, Arévalo L, Andrade-Sierra J, Padilla M, Reveiz L. Álvarez-Moreno CA, et al. Travel Med Infect Dis. 2023 May-Jun;53:102594. doi: 10.1016/j.tmaid.2023.102594. Epub 2023 May 19. Travel Med Infect Dis. 2023. PMID: 37211342 Free PMC article.
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic.
Solante R, Alvarez-Moreno C, Burhan E, Chariyalertsak S, Chiu NC, Chuenkitmongkol S, Dung DV, Hwang KP, Ortiz Ibarra J, Kiertiburanakul S, Kulkarni PS, Lee C, Lee PI, Lobo RC, Macias A, Nghia CH, Ong-Lim AL, Rodriguez-Morales AJ, Richtmann R, Safadi MAP, Satari HI, Thwaites G. Solante R, et al. Expert Rev Vaccines. 2023 Jan-Dec;22(1):1-16. doi: 10.1080/14760584.2023.2143347. Epub 2022 Nov 11. Expert Rev Vaccines. 2023. PMID: 36330971 Free article. Review.
Viral reactivations and co-infections in COVID-19 patients: a systematic review.
Kim JYH, Ragusa M, Tortosa F, Torres A, Gresh L, Méndez-Rico JA, Alvarez-Moreno CA, Lisboa TC, Valderrama-Beltrán SL, Aldighieri S, Reveiz L. Kim JYH, et al. BMC Infect Dis. 2023 Apr 26;23(1):259. doi: 10.1186/s12879-023-08117-y. BMC Infect Dis. 2023. PMID: 37101275 Free PMC article.
Associated factors for mortality in a COVID-19 colombian cohort: is the third wave relevant when Mu variant was predominant epidemiologically?
Alvarez-Moreno C, Valderrama-Beltran SL, Silva R, De La Hoz Siegler IH, Varón Vega FA, Martínez-Vernaza S, Blanco TO, Padilla M, Mesa-Rubio ML, Castañeda Pascagaza LC, Rojas JA, Bravo Ojeda JS, Villa J, Chacón Sarmiento JA, Yomayusa N, Patiño S, Gómez-Nieto K, Martínez Pinzón VL, Ramírez Cogollo AM, Toloza C, Diaz-Puentes M, Cañas-Arboleda A, Manrique-Andrade M, Ayub RT, López Mora MJ, Pachón Espinosa MJ, Cortés JA, Sánchez LC, Chacón Acevedo KR, Rengifo P, Tambini G, Bertagnolio S, Diaz J, Thwin SS, Reveiz L. Alvarez-Moreno C, et al. Travel Med Infect Dis. 2023 May-Jun;53:102579. doi: 10.1016/j.tmaid.2023.102579. Epub 2023 May 9. Travel Med Infect Dis. 2023. PMID: 37169233 Free PMC article.
SARS-CoV-2 vaccination strategies: Should the extended dosing interval strategy be implemented in future pandemics?
Valderrama-Beltrán S, Cuervo-Rojas J, Martinez-Vernaza S, Alvarez-Moreno CA, Rodriguez-Morales AJ. Valderrama-Beltrán S, et al. Among authors: alvarez moreno ca. Travel Med Infect Dis. 2023 Nov-Dec;56:102650. doi: 10.1016/j.tmaid.2023.102650. Epub 2023 Oct 7. Travel Med Infect Dis. 2023. PMID: 37813321 Free article. No abstract available.
Development of a diagnostic multivariable prediction model of a positive SARS-CoV-2 RT-PCR result in healthcare workers with suspected SARS-CoV-2 infection in hospital settings.
Valderrama-Beltrán SL, Cuervo-Rojas J, Rondón M, Montealegre-Diaz JS, Vera JD, Martinez-Vernaza S, Bonilla A, Molineros C, Fierro V, Moreno A, Villalobos L, Ariza B, Álvarez-Moreno C. Valderrama-Beltrán SL, et al. PLoS One. 2024 Dec 26;19(12):e0316207. doi: 10.1371/journal.pone.0316207. eCollection 2024. PLoS One. 2024. PMID: 39724211 Free PMC article.
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
WHO Solidarity Trial Consortium; Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hernández García C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Roses Periago M, Abi Hanna P, Ader F, Al-Bader AM, Alhasawi A, Allum E, Alotaibi A, Alvarez-Moreno CA, Appadoo S, Asiri A, Aukrust P, Barratt-Due A, Bellani S, Branca M, Cappel-Porter HBC, Cerrato N, Chow TS, Como N, Eustace J, García PJ, Godbole S, Gotuzzo E, Griskevicius L, Hamra R, Hassan M, Hassany M, Hutton D, Irmansyah I, Jancoriene L, Kirwan J, Kumar S, Lennon P, Lopardo G, Lydon P, Magrini N, Maguire T, Manevska S, Manuel O, McGinty S, Medina MT, Mesa Rubio ML, Miranda-Montoya MC, Nel J, Nunes EP, Perola M, Portolés A, Rasmin MR, Raza A, Rees H, Reges PPS, Rogers CA, Salami K, Salvadori MI, Sinani N, Sterne JAC, Stevanovikj M, Tacconelli E, Tikkinen KAO, Trelle S, Zaid H, Røttingen JA, Swaminathan S. WHO Solidarity Trial Consortium, et al. N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2. N Engl J Med. 2021. PMID: 33264556 Free PMC article. Clinical Trial.
57 results